In this CME Outfitters Podcast, expert faculty will guide learners to better identify key social needs that impact health outcomes in underserved patient populations and Implement nursing education strategies that address social drivers of health and empower patients through improved health literacy and access to resources.
Tiffany Gibson is a Nurse Leader whose primary focus is creating emotionally intelligent Nurses to change the culture of the profession and demolish outdated norms.
Tiffany challenges nurses to master leadership in themselves so they can master the complicated industry of healthcare. She accomplishes this within her work as a full-time Nurse Director, part-time adjunct faculty member, and all-the-time in Nursing Education Professional Development and Equity & Inclusion Consulting for her business, New Nurse Academy, LLC.
Early on, Tiffany developed a devotedness to learning and leading that continues to this day. She is a graduate of Temple University (2005, Bachelor of Public Health), Drexel University (2008, Bachelor of Nursing), and Walden University (2017, Master of Nursing Education). Tiffany also has a post-graduate certificate in Healthcare Diversity Leadership from the Institute of Emerging Health Professions at Thomas Jefferson University and two national board certifications – one as a Nurse Professional Development Specialist (ANCC) and another from the Pediatric Nursing Certification Board.
With a profound commitment to driving nursing culture forward, Tiffany’s mission is to have unconventional conversations and present opportunities for learning to nurses and hospital administration on the importance of emotional intelligence, self-awareness, psychological safety, and inclusivity. Tiffany is creating a movement to amplify thought leaders and change agents that will change the narrative of nursing.
In this second installment of a CMEO podcast series expert faculty will discuss strategies to better evaluate new and emerging evidence related to biomarkers and imaging that are forging the way toward precision medicine in IBD.
Neilanjan Nandi, FACG, AGAF, FACP, is Associate Professor of Clinical Medicine at Penn Presbyterian Medical Center at the University of Pennsylvania. Dr. Nandi’s practice focuses on the management of inflammatory bowel disease (IBD) (e.g., Crohn’s disease, ulcerative colitis) and recurrent Clostridium difficile (C. difficile) infection via fecal microbiota transplantation (FMT). Dr. Nandi serves on the executive council of the Philadelphia Crohn’s & Colitis Foundation (CCF) and on the medical advisory board of the United Ostomy Associates of America (UOAA), coordinates outreach on the American College of Gastroenterology Patient Care Committee, and is a founding board member of the South Asian IBD Alliance (SAIA). He also regularly peer reviews research publications and serves on the social media editorial board for the premier journals Inflammatory Bowel Diseases and Crohn’s & Colitis 360. His research has focused on studying conditions co-morbid to IBD quality of care, namely the diagnosis and management of refractory C. difficile infection and the application of FMT in C. difficile; also, characterizing the management and consequences of iron deficiency anemia and non-alcoholic fatty liver disease in patients with IBD. Dr. Nandi has authored numerous book chapters on the diagnosis and management of various viral, parasitic, mycobacterial, and bacterial infections of the gastrointestinal (GI) tract.
Dr. Nandi’s fervor for clinical education has been recognized with multiple teaching awards. He was honored as the 2019 Physician Hero by the Philadelphia/Delaware Valley Crohn’s and Colitis Foundation at their annual Take Steps for Crohn’s & Colitis event, and wields digital and social media platforms to amplify education, outreach, and advocacy in IBD to clinicians and patients. He was also awarded the Philadelphia CCF’s Chairman’s Citation in 2022. He is the regular host of the academic podcast GI Insights: IBD Crosstalk, which features high-yield, evidence-based medicine discussions with guests from different interdisciplinary fields critical to providing comprehensive IBD care. Dr. Nandi’s passions include fitness, cooking, virtual reality gaming, reading, and dancing. Follow him on social @fitwitmd.
In this first installment of a CMEO podcast series expert faculty will discuss strategies to identify new and emerging pathological targets, evaluate new and emerging evidence related to these novel targets, and the importance of these targets in treatment decision-making.
Neilanjan Nandi, FACG, AGAF, FACP, is Associate Professor of Clinical Medicine at Penn Presbyterian Medical Center at the University of Pennsylvania. Dr. Nandi’s practice focuses on the management of inflammatory bowel disease (IBD) (e.g., Crohn’s disease, ulcerative colitis) and recurrent Clostridium difficile (C. difficile) infection via fecal microbiota transplantation (FMT). Dr. Nandi serves on the executive council of the Philadelphia Crohn’s & Colitis Foundation (CCF) and on the medical advisory board of the United Ostomy Associates of America (UOAA), coordinates outreach on the American College of Gastroenterology Patient Care Committee, and is a founding board member of the South Asian IBD Alliance (SAIA). He also regularly peer reviews research publications and serves on the social media editorial board for the premier journals Inflammatory Bowel Diseases and Crohn’s & Colitis 360. His research has focused on studying conditions co-morbid to IBD quality of care, namely the diagnosis and management of refractory C. difficile infection and the application of FMT in C. difficile; also, characterizing the management and consequences of iron deficiency anemia and non-alcoholic fatty liver disease in patients with IBD. Dr. Nandi has authored numerous book chapters on the diagnosis and management of various viral, parasitic, mycobacterial, and bacterial infections of the gastrointestinal (GI) tract.
Dr. Nandi’s fervor for clinical education has been recognized with multiple teaching awards. He was honored as the 2019 Physician Hero by the Philadelphia/Delaware Valley Crohn’s and Colitis Foundation at their annual Take Steps for Crohn’s & Colitis event, and wields digital and social media platforms to amplify education, outreach, and advocacy in IBD to clinicians and patients. He was also awarded the Philadelphia CCF’s Chairman’s Citation in 2022. He is the regular host of the academic podcast GI Insights: IBD Crosstalk, which features high-yield, evidence-based medicine discussions with guests from different interdisciplinary fields critical to providing comprehensive IBD care. Dr. Nandi’s passions include fitness, cooking, virtual reality gaming, reading, and dancing. Follow him on social @fitwitmd.
In this third installment of a CMEO podcast series expert faculty will discuss strategies to better apply precision medicine to emerging IBD therapies such as TL1A inhibitors as a means of closing gaps in care.
Neilanjan Nandi, FACG, AGAF, FACP, is Associate Professor of Clinical Medicine at Penn Presbyterian Medical Center at the University of Pennsylvania. Dr. Nandi’s practice focuses on the management of inflammatory bowel disease (IBD) (e.g., Crohn’s disease, ulcerative colitis) and recurrent Clostridium difficile (C. difficile) infection via fecal microbiota transplantation (FMT). Dr. Nandi serves on the executive council of the Philadelphia Crohn’s & Colitis Foundation (CCF) and on the medical advisory board of the United Ostomy Associates of America (UOAA), coordinates outreach on the American College of Gastroenterology Patient Care Committee, and is a founding board member of the South Asian IBD Alliance (SAIA). He also regularly peer reviews research publications and serves on the social media editorial board for the premier journals Inflammatory Bowel Diseases and Crohn’s & Colitis 360. His research has focused on studying conditions co-morbid to IBD quality of care, namely the diagnosis and management of refractory C. difficile infection and the application of FMT in C. difficile; also, characterizing the management and consequences of iron deficiency anemia and non-alcoholic fatty liver disease in patients with IBD. Dr. Nandi has authored numerous book chapters on the diagnosis and management of various viral, parasitic, mycobacterial, and bacterial infections of the gastrointestinal (GI) tract.
Dr. Nandi’s fervor for clinical education has been recognized with multiple teaching awards. He was honored as the 2019 Physician Hero by the Philadelphia/Delaware Valley Crohn’s and Colitis Foundation at their annual Take Steps for Crohn’s & Colitis event, and wields digital and social media platforms to amplify education, outreach, and advocacy in IBD to clinicians and patients. He was also awarded the Philadelphia CCF’s Chairman’s Citation in 2022. He is the regular host of the academic podcast GI Insights: IBD Crosstalk, which features high-yield, evidence-based medicine discussions with guests from different interdisciplinary fields critical to providing comprehensive IBD care. Dr. Nandi’s passions include fitness, cooking, virtual reality gaming, reading, and dancing. Follow him on social @fitwitmd.
In the sixth activity of this CME Outfitters podcast series on gynecologic cancers, expert faculty will present and discuss the very latest research on treatment options for cervical cancer, including recently approved treatments, and how to choose between them for patients with recurrent cervical cancer.
In this CME Outfitters Podcast, expert faculty will discuss utilization of current and emerging screening and diagnostic tools in diverse populations for detection of AD early in the disease course; integration of culturally sensitive patient and caregiver education strategies to improve shared decision-making on brain health and/or AD management with patients; and implementation of MDT care when treating patients with AD.
